Figures & data
![](/cms/asset/3261882b-c359-4619-8f36-7fbdbc51cfb4/ianb_a_1443940_uf0001_c.jpg)
Table 1. Physical characteristics of microsphere formulations with different inner phases.
Figure 3. DSC thermograms (a) and XRPD patterns (b) of blank microspheres. LP: physical mixture and LP-MSs.
![Figure 3. DSC thermograms (a) and XRPD patterns (b) of blank microspheres. LP: physical mixture and LP-MSs.](/cms/asset/d85a991e-fcf4-4106-9bce-6fb65045a5a8/ianb_a_1443940_f0003_c.jpg)
Figure 4. Degradation of different LP-loaded microspheres after exposure to PBS (pH 6.8) at 37 °C (n = 3) (***labels significant differences).
![Figure 4. Degradation of different LP-loaded microspheres after exposure to PBS (pH 6.8) at 37 °C (n = 3) (***labels significant differences).](/cms/asset/4baf914a-d4ca-4a34-8367-a5f6742cadd7/ianb_a_1443940_f0004_c.jpg)
Figure 5. SEM images of different inner phase of liquid (1), Gel 1 (2), Gel 2 (3) and solid (4) before and after exposure to PBS (pH 6.8).
![Figure 5. SEM images of different inner phase of liquid (1), Gel 1 (2), Gel 2 (3) and solid (4) before and after exposure to PBS (pH 6.8).](/cms/asset/e00a8c7a-7285-4da0-bc2e-e787f2e25eeb/ianb_a_1443940_f0005_c.jpg)
Figure 6. In vitro drug release profiles of LP-MSs with different inner phases, at 37 °C in PBS (pH 6.8) (n = 3).
![Figure 6. In vitro drug release profiles of LP-MSs with different inner phases, at 37 °C in PBS (pH 6.8) (n = 3).](/cms/asset/d2eb6375-c849-47f4-9c72-ca27fc4e2170/ianb_a_1443940_f0006_c.jpg)
Figure 7. Plasma LP concentrations in rats received controlled group and experiment group of preparations with different inner phases, respectively (n = 5).
![Figure 7. Plasma LP concentrations in rats received controlled group and experiment group of preparations with different inner phases, respectively (n = 5).](/cms/asset/23e0157d-3dd9-4229-9448-b90c217143b0/ianb_a_1443940_f0007_c.jpg)
Table 2. Pharmacokinetic evaluation parameters of drug in SD rats after oral and intramuscular administrations of LP solution and LP-loaded MSs.